You are here

News & Opinion

Opinion / When the law intervenes in peer review - articles from the International Journal of Forensic Mental Health

There’s a interesting paper and editorial published in May in the International Journal of Forensic Mental Health. The article is entitled PCL-R Psychopathy: Threats to Sue, Peer Review, and Implications for Science and Law.

Opinion / CMAJ news story on funding withdrawal for Canadian Research ethics council

The news story reports that the National Council on Ethics in Human Research (NCEHR), has had its funding withdrawn by Health Canada and the Canadian Institutes of Health Research.  Apparently this will primarily affect education, but also scotches the possibility that the Council would devolp into a Canadian national accrediting and oversight body for research ethics boards.

News

Ethical editing - Summer 2010 issue

Download the Summer issue of Ethical Editing, the newsletter from COPE (http://publicationethics.org/newsletters).
This issue's theme is Plagiarism, following on from our recent annual seminar. We would very much welcome any feedback or comments you may have. Please contact us via the website.

Opinion / Nature news story on publication of trial data

The story relates to an announcement on June 10 by the International Federation of Pharmaceutical Manufacturers and Associations.  An exerpt from the IFPMA press release states:

Opinion / A report of the second seminar of Iranian Medical Journal editors

We received this report from Behrooz Astaneh, Deputy Editor of the Iranian Journal of Medical Sciences.

Behrooz can be contacted on [email protected]

The second seminar of Iranian Medical Journal editors- A Report

News

Forum agenda for 8 June 2010 meeting

Download the agenda and materials for the 8 June 2010 Forum (Download PDF, 237kb).

Opinion / Review in trials on reporting bias/witholding data in (industry) medical research - with lots of examples

Well worth reading. http://www.trialsjournal.com/content/pdf/1745-6215-11-37.pdf
The overall message and the recommendations aren't new, but thus is a succinct and informative review by the German health technology asessement body that's worth citing and using in talks. It includes and goes well beyond the usual suspects (rofecoxib, gabapentin, SSRIs, rosiglitazone, oseltamivir) and gives a really nice overview of all the recent attempts to make people behave better eg through trial registration.

News

Editing Medical Journals: Short Course

Date: 10-12 November 2010
Location: Oxford, UK
Website: http://www.pspconsulting.org

Opinion / Journals are failing to publish conflict of interest statements

A study by Wang et al in the BMJ (340:c1344) found that 21 out of 90 papers (23%) reporting studies on the antidiabetic agent rosiglitazone had incomplete Conflict of Interest information and 3 of the 21 stated that the authors had no competing interests although their other publications indicated that they did.

It's possible that this may, partly, be explained by journals using different thresholds for CoIs, but it suggests that editors may not be requesting or checking CoI statements sufficiently thoroughly.

Opinion / The culture of compliments: when flowcharts can't help

Over at the BMJ blogs, Behrooz Astaneh has written an interesting perspective on the "culture of compliments", which exists in many cultures. He notes that because of this culture "authors feel compelled to put the name of a senior colleague in the byline of their article even though the senior researcher did not contribute to it because they feel it would be rude not to.

Pages